Geron Corp (GERN)

2.07 -0.08 (-3.72%) USD  |  NASDAQ  |  Aug 18, 13:15
More

Geron News

News

Headline
Wire
Time (ET)
Update: Geron Reports Narrower Q2 Loss, Lower Revenue; Shares Advance Friday
MT Newswires
08/12 12:06
J&J (JNJ) to Stop Selling Talc-based Baby Powder From 2023
Yahoo
08/12 11:21
Geron rises on narrower-than-expected Q2 loss
SA Breaking News
08/12 10:45
Geron Reports Narrower Q2 Loss, Revenue Declines; Shares Rise in Premarket
MT Newswires
08/12 08:05
Geron (GERN) Q2 2022 Earnings Call Transcript
Yahoo
08/11 23:00
Small Caps Begin to Rebound: 10 Stocks to Buy Now
Yahoo
08/11 17:24
Geron Corporation Reports Second Quarter 2022 Financial Results
Yahoo
08/11 16:05
Top Penny Stocks for August 2022
Yahoo
08/11 13:27
Allogene (ALLO) Q1 Earnings Beat, Pipeline Progressing Well
Yahoo
08/10 14:54
Perrigo's (PRGO) Q2 Earnings Misses by a Cent, Sales Beat
Yahoo
08/09 12:14
Karuna (KRTX) Lags on Q2 Earnings, Up 71% on Schizophrenia Data
Yahoo
08/09 12:03
Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022
Yahoo
08/04 16:30
All You Need to Know About Geron (GERN) Rating Upgrade to Strong Buy
Yahoo
08/04 12:00
Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference
Yahoo
08/03 16:30
--B. Riley Resumes Geron at Buy with $4 Price Target, Says Thesis Hinges on Potential Success of Imetelstat
MT Newswires
07/28 09:57
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
07/21 19:05
7 Best Penny Stocks Under $3 to Buy in July
Yahoo
07/13 10:18
VERU's Shares Jump on Successful COVID-19 Study Results
Yahoo
07/08 11:44
Exelixis (EXEL) Collaborates With Ryvu for Cancer Therapies
Yahoo
07/07 11:30
Geron extends winning streak to reach 52-week high
SA Breaking News
07/05 11:25
Novartis (NVS) Announces Positive Data on Oncology Drug
Yahoo
07/01 11:01
Geron Secures Additional $50 Million in Loan Capacity Through End of 2024
MT Newswires
06/30 16:39
Geron Corporation Announces Expansion of Existing Loan Facility
Yahoo
06/30 16:15
Gilead's (GILD) Yescarta Gets EC Nod for Follicular Lymphoma
Yahoo
06/29 10:28
Gilead (GILD) Resubmits NDA for HIV Inhibitor to the FDA
Yahoo
06/28 08:49
Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation
Yahoo
06/27 13:21
Bristol Myers (BMY) Breyanzi Gets FDA Nod for Label Expansion
Yahoo
06/27 13:06
Gilead (GILD) Announces Positive Data on Hepcludex for HDV
Yahoo
06/24 12:30
Exelixis (EXEL), BioInvent Tie Up for Immuno-Oncology Therapies
Yahoo
06/17 11:31
Bausch (BHC) Suspends IPO Plans for Solta Medical
Yahoo
06/17 09:36
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
06/16 16:30
Roche (RHHBY) Alzheimer's Disease Drug Data Disappoints
Yahoo
06/16 12:15
Geron Names Faye Feller Chief Medical Officer
MT Newswires
06/15 16:28
Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role
Yahoo
06/15 16:10
Zacks Industry Outlook Highlights Alkermes, Geron, Immunocore and BELLUS Health
Yahoo
06/13 06:13
4 Biotech Stocks With Bright Prospects to Buy Amid Recovery
Yahoo
06/10 11:57
Has Geron (GERN) Outpaced Other Medical Stocks This Year?
Yahoo
06/10 09:40
Mirati (MRTX) Up on Positive Data From NSCLC Study on Adagrasib
Yahoo
06/08 11:45
Lead Plaintiffs and Class Representatives Julia Junge and Richard Junge Announce Summary Notice of Pendency of Class Action (Nasdaq: GERN)
PR Newswire
06/06 08:00
Examining Penny Stocks with Technical Analysis for June 2022
Yahoo
05/31 11:56
Does Geron (NASDAQ:GERN) Have A Healthy Balance Sheet?
Yahoo
05/31 09:21
Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah
Yahoo
05/30 15:10
Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
Yahoo
05/30 15:03
Regeneron's (REGN) Evkeeza Positive in Late-Stage Study
Yahoo
05/23 12:26
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA
Yahoo
05/23 11:46
--Needham Trims Geron's Price Target to $2 From $3, Buy Rating Kept
MT Newswires
05/10 11:14
Notable earnings after Monday's close
SA Breaking News
05/08 17:35
Geron Completes Stock, Warrant Sale
MT Newswires
04/01 16:51
Top Premarket Decliners
MT Newswires
03/30 08:11
Geron slumps on pricing $75M stock and warrants offering
SA Breaking News
03/30 03:43
Geron Prices Offering of Common Shares, Warrants; Expects $75 Million Gross Proceeds
MT Newswires
03/30 03:25
Geron Plans Securities Offering -- Shares Plunge After-Hours
MT Newswires
03/29 16:15
Morgan Stanley projects about a third of biotechs will need financing in 2022
SA Breaking News
03/26 12:00
Earnings Reaction History: GERON CORP, 44.4% Follow-Through Indicator, 4.2% Sensitive
MT Newswires
03/10 12:09
Geron appoints chief business officer
SA Breaking News
12/02 09:13
Geron slips despite quarterly EPS, revenue beat
SA Breaking News
11/10 14:01
--Baird Starts Geron at Outperform With $4 Price Target
MT Newswires
11/02 05:55
Geron Gets UK's Innovative Passport Label for Imetelstat to Expedite Regulatory Process -- Stock Up 7% After-Hours
MT Newswires
10/25 17:44
Geron Completes Patient Enrollment in Phase 3 Trial of Imetelstat
MT Newswires
10/18 08:20
After Hours Watch List Scorecard: QTRX, GERN, RLAY
MT Newswires
10/12 17:10
MT Newswires After Hours Watch List: QTRX, GERN, RLAY
MT Newswires
10/11 17:35
Geron's Imetelstat Shows Survival Benefit in BLood Cancer Trial -- Stock Up 8% After-Hours
MT Newswires
10/11 17:19
Meet members of the 2021 IPO class: Biotechs - 2
SA Breaking News
09/28 10:09
Geron Logs Wider Q2 Loss as Revenue Rises, Sees Myelodysplasia Trial Fully Enrolled in Q4
MT Newswires
08/16 17:07
Earnings Reaction History: GERON CORP, 44.4% Follow-Through Indicator, 4.2% Sensitive
MT Newswires
08/16 12:32
Thinking about buying stock in ContextLogic, Adial Pharmaceuticals, Geron Corp, Orphazyme, or Citius Pharmaceuticals?
PR Newswire
06/22 10:45
Thinking about buying stock in Geron Corp, Ashford Hospitality Trust, Paratek Pharmaceuticals, Seanergy Maritime, or TAL Education?
PR Newswire
06/21 10:55
MicroStrategy, Marathon Digital among premarket losers' pack
SA Breaking News
06/21 08:19
After Hours Watch List Scorecard: GERN, CGRN, ATHA,
MT Newswires
06/18 16:32
CGRN, CLNE, GERN and CURI among midday movers
SA Breaking News
06/18 12:44
Geron shares shoot up 51% on phase 2 data for myelofibrosis candidate
SA Breaking News
06/18 12:31
Geron, AnPac Bio-Medical Science leads healthcare gainers; Orphazyme, Athira Pharma among major losers
SA Breaking News
06/18 11:01
Hot Stocks: BMY collaboration, CAI merger deal, GERN pops on clinical trial
SA Breaking News
06/18 09:21
Sector Update: Health Care Stocks Lower in Premarket Friday
MT Newswires
06/18 09:04
Thinking about buying stock in Geron Corp, Vaxart, Orphazyme, Athira Pharma, or TAL Education?
PR Newswire
06/18 08:30
GEO, GERN, SWBI and CVAC among premarket gainers
SA Breaking News
06/18 08:19
Geron surges after publication of IMbark Phase 2 data
SA Breaking News
06/17 23:22
MT Newswires After Hours Watch List: GERN, CGRN, ATHA
MT Newswires
06/17 17:50
Geron's Drug Candidate Shows Benefits in Bone Marrow Cancer Mid-Stage Trial -- Stock Jumps 21% After-Hours
MT Newswires
06/17 17:04
Geron EPS misses by $0.01, beats on revenue
SA Breaking News
05/10 16:06
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm
Globe Newswire
04/27 04:36
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C.
Globe Newswire
04/20 16:00
SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading
PR Newswire
04/19 09:30
Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL)
Globe Newswire
04/18 08:00
Geron Doses First Patient in Phase 3 Study of Potential Blood Cancer Drug Imetelstat
MT Newswires
04/13 08:15
Geron starts dosing in late-stage blood cancer study
SA Breaking News
04/13 07:41
Geron Narrows Q4 Loss, Sees FY21 Expense of About $110 Million; Stock Down 4% After Hours
MT Newswires
03/11 17:23
Geron EPS in-line, beats on revenue
SA Breaking News
03/11 16:17
Geron Opens Patient Screening, Enrollment for Phase 3 Clinical Trial in Refractory Myelofibrosis
MT Newswires
12/11 10:56
Geron launches late-stage imetelstat study in refractory myelofibrosis
SA Breaking News
12/11 09:03
Geron Enrolls 50% of Target Patient Population in Study of Blood Cancer Drug Candidate Imetelstat
MT Newswires
12/10 09:42
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
Globe Newswire
11/05 16:05
Geron Signs up for $75 Million Loan Facility
MT Newswires
10/01 16:42
Geron secures up to $75M non-dilutive financing
SA Breaking News
10/01 16:37
Geron to Present at the H.C. Wainwright Global Investment Conference
Business Wire
09/09 09:00
Geron Files $350 Million Mixed Shelf
MT Newswires
09/08 05:51
Analyst Actions: HC Wainwright Raises Geron's Price Target to $7 From $4, Reiterates Buy Rating
MT Newswires
08/26 10:52
CRM, HPE among premarket gainers
SA Breaking News
08/26 08:21
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
08/20 16:30
Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events
Business Wire
08/06 16:05
Geron to Present at the BTIG Virtual Biotechnology Conference
Business Wire
08/04 16:45
Analyst Actions: Stifel Nicolaus Initiates Coverage on Geron With Buy Rating, $3 Price Target
MT Newswires
08/03 09:11
MPC, GERN among premarket gainers
SA Breaking News
08/03 08:27
Geron to Announce Second Quarter Financial Results on August 6, 2020
Business Wire
07/30 16:30
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
07/16 08:30
REGN, NIO, GERN and SLCA among after-hours movers
SA Breaking News
07/02 17:48
Geron Wins European Committee OK for Orphan Drug Designation of Potential Myelodysplastic Syndromes Treatment
MT Newswires
07/01 09:03
Geron poised to nab Orphan Drug tag in Europe for imetelstat for bone marrow disorder
SA Breaking News
07/01 08:43
Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic Syndromes
Globe Newswire
07/01 08:30
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress
Globe Newswire
06/12 08:30
Analyst Actions: Cantor Fitzgerald Lifts Geron's Price Target to $4 From $3, Reiterates Overweight Rating
MT Newswires
06/01 09:37
Analyst Actions: B. Riley Lifts Geron Price Target to $4 From $3.50, Maintains Buy Rating
MT Newswires
05/29 12:26
VMW, MRVL among premarket gainers
SA Breaking News
05/29 09:21
Geron Q1 Loss Widens, Revenue Falls
MT Newswires
05/28 17:15
-- Earnings Flash (GERN) GERON CORP Posts Q1 EPS $-0.08
MT Newswires
05/28 16:14
Geron EPS beats by $0.04, revenue in-line
SA Breaking News
05/28 16:07
Geron Corporation Reports First Quarter 2020 Financial Results
Globe Newswire
05/28 16:05
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
Globe Newswire
05/27 16:30
Healthcare - Top 5 Gainers / Losers
SA Breaking News
05/22 11:13
Geron Prices Public Sale of Common Shares, Warrants
MT Newswires
05/22 09:28
FL, HPE among premarket losers
SA Breaking News
05/22 09:19
Wall Street Wavers Prebell As US-China Tensions Escalate
MT Newswires
05/22 09:06
Geron under pressure after pricing equity offering
SA Breaking News
05/22 07:34
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
Globe Newswire
05/22 07:15
Geron readies equity offering
SA Breaking News
05/22 04:18
Geron to launch late-stage study of imetelstat in myelofibrosis
SA Breaking News
05/21 17:17
Geron Sheds 13% - Plans Phase 3 Trial in Refractory Myelofibrosis but Other Development Delayed, Issues OpEx Burn Rate for 2020, Plans Offering
MT Newswires
05/21 16:14
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
Globe Newswire
05/21 16:03
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
Globe Newswire
05/21 16:01
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
05/21 08:30
Aurora Cannabis leads healthcare gainers; Midatech Pharma tops the losers
SA Breaking News
05/18 11:08
Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress
Business Wire
05/14 09:05
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
04/16 08:30
Geron to Present at Needham Virtual Healthcare Conference
Globe Newswire
04/08 16:30
--Analyst Actions: BTIG Cuts Geron's Price Target to $3 From $4, Keeps Buy Rating
MT Newswires
04/03 10:47
Geron Expects Delays in IMerge Trial Enrollment, Study on High-Risk MDS and AML Due to COVID-19 Pandemic
MT Newswires
04/02 08:33
More COVID-19 actions - healthcare
SA Breaking News
04/02 08:31
Geron Provides COVID-19 Related Business Update
Globe Newswire
04/02 08:00
MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation and Encourages Investors with Losses to Contact the Firm
Business Wire
03/23 10:40
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline 3 Days Away, Investors with Losses Encouraged to Contact Firm
Globe Newswire
03/20 17:14
GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm
Business Wire
03/19 11:00
GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm
Globe Newswire
03/17 10:00
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 8 Days Remain Until Application Deadline, Investors with Losses Encouraged to Contact Firm
Globe Newswire
03/15 15:09
MT Newswires After-Hours News Movers
MT Newswires
03/12 17:57
Geron Q4 Results Best Estimates, Sets Operating Expense Outlook - Stock Up 2% After-Hours
MT Newswires
03/12 16:36
Geron Corporation Reports Fourth Quarter and Full Year 2019 Financial Results and 2020 Milestones
Globe Newswire
03/12 16:05
Earnings Reaction History: GERON CORP, 66.7% Follow-Through Indicator, 14.2% Sensitive
MT Newswires
03/12 14:56
GERN & CCI SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Notifies Investors of Class Actions and Encourages Investors to Contact the Firm
Globe Newswire
03/12 14:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qudian, Geron Corporation, Opera Limited, and Beyond Meat and Encourages Investors to Contact the Firm
Globe Newswire
03/11 14:36
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors to 2 Week Deadline: Investors Who Suffered Losses Encouraged to Contact Firm
Globe Newswire
03/09 20:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline – GERN
Globe Newswire
03/09 17:03
GERN INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm
Business Wire
03/09 15:00
Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Geron Corporation
Business Wire
03/05 18:14
Geron to Announce Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Business Wire
03/05 16:30
QD & GERN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines
Globe Newswire
03/05 10:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm
Globe Newswire
03/04 12:00
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline – GERN
Globe Newswire
03/03 14:47
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Suffered Losses to Contact its Attorneys: Application Deadline in Three Weeks
Globe Newswire
03/02 20:00
INVESTOR ALERT - Geron Corporation (GERN) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 23, 2020
Globe Newswire
02/27 10:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 500.com, Portola Pharmaceuticals, Qudian, and Geron Corporation and Encourages Investors to Contact the Firm
Globe Newswire
02/26 12:57
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Geron Corporation (GERN) Investors With Losses to Contact its Attorneys: Application Deadline Approaching
Globe Newswire
02/24 19:55
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline – GERN
Globe Newswire
02/24 16:19
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Geron Corporation of Class Action Lawsuit and Upcoming Deadline - GERN
PR Newswire
02/20 17:46
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
02/20 08:00
SHAREHOLDER ALERT: CLAIMSFILER REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Globe Newswire
02/19 22:50
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of GERN, OPRA and QD
Globe Newswire
02/18 22:50
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Geron Corporation (GERN) Investors With Losses to Contact its Attorneys: Application Deadline Approaching
Globe Newswire
02/18 20:06
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Globe Newswire
02/17 22:50
SHAREHOLDER ALERT: CLAIMSFILER REMINDS GERN, OPRA, QD INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Globe Newswire
02/14 22:50
Pomerantz Law Firm Announces the Filing of a Class Action against Geron Corporation and Certain Officers – GERN
Globe Newswire
02/14 16:08
GERN Stock: Berger Montague Investigates Securities Fraud Class Action Claims Against Geron Corporation (NASDAQ: GERN); Lead Plaintiff Deadline is March 23, 2020
PR Newswire
02/14 14:23
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation
Globe Newswire
02/13 11:30
GERON DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
Business Wire
02/13 09:32
GERON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Geron Corporation - GERN
Business Wire
02/12 19:30
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qudian, Geron Corporation, Opera Limited, and Beyond Meat and Encourages Investors to Contact the Firm
Globe Newswire
02/12 15:00
GERN Investors: March 23, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser
Business Wire
02/11 09:00
DEADLINE ALERT for GDOT,  MHK,  GERN and OPRA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
02/11 08:30
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Geron Corporation (GERN) Investors With Losses to Contact its Attorneys; Application Deadline Pending
Globe Newswire
02/10 20:04
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Globe Newswire
02/10 16:23
GERN DEADLINE: Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against  Geron Corporation – GERN
Globe Newswire
02/10 10:48
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation
Globe Newswire
02/06 12:00
INVESTOR ALERT - Geron Corporation (GERN) - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Deadline: March 23, 2020
Globe Newswire
02/06 10:00
GERON INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
Business Wire
02/05 21:57
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation (GERN)
Globe Newswire
02/05 21:27
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Globe Newswire
02/04 13:48
DEADLINE ALERT for EXC, TCNNF, WBAI, and GERN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
02/04 12:00
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Geron Corporation (GERN) Investors Who Have Suffered Significant Losses to Contact its Attorneys; Securities Class Action Filed
Globe Newswire
02/03 18:52
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Geron Corporation– GERN
Globe Newswire
02/03 10:25
GERON DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Geron Corporation To Contact The Firm
Globe Newswire
02/03 02:03
GERN INVESTOR ALERT: ROSEN, A LEADING LAW FIRM, Reminds Geron Corporation Investors of Important Deadline in Securities Class Action – GERN
Business Wire
02/01 11:15
GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors in Geron Corporation
PR Newswire
01/31 16:00
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Geron Corporation (GERN)
Business Wire
01/31 13:17
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation
Business Wire
01/31 13:00
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation
Business Wire
01/30 12:30
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Geron Corporation (GERN)
Business Wire
01/30 09:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Qudian, Geron Corporation, and Opera Limited and Encourages Investors to Contact the Firm
Globe Newswire
01/29 12:00
GERON CORPORATION INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action has been filed in the United States District Court for the Northern District of California on behalf of investors in Geron Corporation
Globe Newswire
01/28 17:58
GERON CORPORATION ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Geron Corporation and Encourages Investors to Contact the Firm
Business Wire
01/27 19:48
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Geron Corporation - GERN
Globe Newswire
01/27 15:14
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Business Wire
01/27 11:20
SHAREHOLDER ALERT - Geron Corporation (GERN) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: March 23, 2020
Globe Newswire
01/27 10:00
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Geron Corporation (GERN) Who Have Suffered Significant Losses to Contact its Attorneys: Securities Fraud Case Filed
Globe Newswire
01/27 08:30
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Investors in Geron Corporation (GERN) Who Have Suffered Significant Losses to Contact its Attorneys: Securities Fraud Case Filed
PR Newswire
01/25 15:01
GERN LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Geron Corporation - GERN
PR Newswire
01/25 13:00
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Geron Corporation (GERN)
Globe Newswire
01/24 19:30
EQUITY ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Geron Corporation – GERN
Business Wire
01/24 10:24
Johnson Fistel, LLP Announces That It Has Filed a Class Action Against Geron Corporation
PR Newswire
01/23 23:01
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
01/16 08:00
Geron Announces 2019 Accomplishments and Key Development Priorities for 2020
Business Wire
01/13 08:00
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
12/19 08:00
MT Newswires After-Hours News Movers
MT Newswires
12/18 17:46
Geron Ends Phase 2 Trial Meeting With FDA Over Treatment of Bone Marrow Cancer
MT Newswires
12/18 16:54
Geron Conducts End of Phase 2 Meeting for Imetelstat in Relapsed/Refractory Myelofibrosis
Business Wire
12/18 16:30
Geron Reports Two Poster Presentations at American Society of Hematology Annual Meeting
Business Wire
12/10 09:15
Geron Announces Appointment of New Executive to Focus on Corporate Strategy
Business Wire
12/03 08:00
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
11/21 08:00
Analyst Actions: B. Riley Initiates Coverage on Geron With Buy Rating, $4 Price Target
MT Newswires
11/19 09:24
Evercore downgrades bluebird bio and Clovis in premarket analyst action
SA Breaking News
11/19 08:12
Geron Corporation Reports Third Quarter 2019 Financial Results and Recent Events
Globe Newswire
11/06 16:10
Geron Announces Two Poster Presentations at Upcoming American Society of Hematology Annual Meeting
Globe Newswire
11/06 09:18
Geron (GERN) Alert: Johnson Fistel Launches Investigation into Geron Corporation; Investors Encouraged to Contact Firm
PR Newswire
10/29 07:00
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
10/17 16:10
Sector Update: Health Care Stocks Adding to Earlier Gains
MT Newswires
10/11 15:59
Sector Update: Health Care Stocks Mostly Higher in Friday Surge
MT Newswires
10/11 13:41
Sector Update: Health Care Majors Trade Higher Pre-Bell Friday
MT Newswires
10/11 09:20
Geron launches late-stage IMerge trial in lower risk MDS
SA Breaking News
10/11 06:09
MT Newswires After-Hours News Movers
MT Newswires
10/10 17:49
Geron Doses First Patient in Late-Stage Trial in Lower Risk Myelodysplastic Syndromes
MT Newswires
10/10 17:38
Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
Globe Newswire
10/10 17:30
After Hours Watch List Scorecard: GERN, NLNK, ROYT
MT Newswires
10/01 17:05
Sector Update: Late Buying Aids Health Care Stocks
MT Newswires
10/01 16:00
Sector Update: Biotechs Weighing on Health Care Stocks
MT Newswires
10/01 13:47
AMTD, ETFC, JFIN and NIO among midday movers
SA Breaking News
10/01 12:46
Sector Update: Health Care Majors Flat To Higher Pre-Bell Tuesday
MT Newswires
10/01 09:19
Wall Street Posts Cautious Gains Pre-Bell Ahead of Manufacturing Data
MT Newswires
10/01 09:17
Thin ranks among premarket gainers
SA Breaking News
10/01 09:05
Sector Update: Health Care
MT Newswires
10/01 09:00
MT Newswires After-Hours Watch List: GERN, NLNK, ROYT
MT Newswires
09/30 17:52
MT Newswires After-Hours News Movers
MT Newswires
09/30 17:48
Geron Lands Fast Track Designation From FDA for Imetelstat to Treat Patients With Myelofibrosis
MT Newswires
09/30 16:36
Geron +12.7% on fast-track designation
SA Breaking News
09/30 16:34
Geron Announces Fast Track Designation Granted to Imetelstat for Relapsed/Refractory Myelofibrosis
Globe Newswire
09/30 16:19
Geron to Present at 2019 Cantor Global Healthcare Conference
Globe Newswire
09/26 16:18
Analyst Actions: HC Wainwright Initiates Coverage on Geron With Buy Rating, $4 Price Target
MT Newswires
09/03 09:40
Sell-siders like InMode in premarket analyst action
SA Breaking News
09/03 08:49
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
08/22 16:18
Sintx Technologies leads healthcare gainers; Cytosorbents and Genetic Technologies among losers
SA Breaking News
08/15 11:02
WMT, CSIQ among premarket gainers
SA Breaking News
08/15 09:08
Analyst Actions: Cantor Fitzgerald Starts Geron at Overweight With $4 Price Target
MT Newswires
08/15 08:16
Cantor sees 210% upside in Geron in premarket analyst action
SA Breaking News
08/15 07:42